COVID-19 Clinical Trials in New York, New York

5 studies are recruiting for covid-19 in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

   This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.

   Stage

   Phase 3

   Ages

   Any age

   Site

   Weill Cornell Medical College, New York, New York

   Locations

   28 in total

   Run by

   Ansun Biopharma, Inc.

   See if you can join NCT03808922 on ClinicalTrials.gov

2. ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

   The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 cris…

   Stage

   Not phased

   Ages

   18 and older

   Site

   NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York, New York

   Run by

   Columbia University

   See if you can join NCT04367857 on ClinicalTrials.gov

3. Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

   The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identif…

   Stage

   Not phased

   Ages

   18 and older

   Site

   New York Presbyterian Queens, New York, New York

   Locations

   3 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT05164744 on ClinicalTrials.gov

4. Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

   The 2019-2020 COVID-19 pandemic is the largest outbreak in recent history. It is not known how long after someone gets sick with COVID-19 and recovers that they can still infect other people. It is also not known how quickly people make antibodies against the virus, which help clear infection from …

   Stage

   Not phased

   Ages

   7 and older

   Site

   Columbia University Medical Center, New York, New York

   Run by

   Columbia University

   See if you can join NCT04448145 on ClinicalTrials.gov

5. EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

   The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and efficacy (how well a study treatment works in the study) of the study medicine (called nirmatrelvir/r…

   Stage

   Phase 3

   Ages

   0 to 17

   Site

   Columbia University Irving Medical Center, New York, New York

   Locations

   73 in total

   Run by

   Pfizer

   See if you can join NCT05261139 on ClinicalTrials.gov